Daniel K. Spiegelman has not been actively trading shares of Myriad Genetics within the last three months. Most recently, Daniel K. Spiegelman sold 6,424 shares of the business's stock in a transaction on Monday, June 6th. The shares were sold at an average price of $19.25, for a transaction totalling $123,662.00. Following the completion of the sale, the director now directly owns 33,980 shares of the company's stock, valued at $654,115. Learn More on Daniel K. Spiegelman's trading history.